CGA
Crescent Grove Advisors’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $234K | Buy |
+300
| New | +$234K | 0.02% | 253 |
|
|
2024
Q2 | – | Sell |
-2,894
| Closed | -$2.25M | – | 301 |
|
|
2024
Q1 | $2.25M | Sell |
2,894
-100
| -3% | -$77.8K | 0.23% | 66 |
|
|
2023
Q4 | $1.75M | Sell |
2,994
-20
| -0.7% | -$11.7K | 0.19% | 73 |
|
|
2023
Q3 | $1.62M | Buy |
3,014
+64
| +2% | +$34.4K | 0.2% | 76 |
|
|
2023
Q2 | $1.38M | Sell |
2,950
-29
| -1% | -$13.6K | 0.15% | 89 |
|
|
2023
Q1 | $1.02M | Buy |
2,979
+100
| +3% | +$34.3K | 0.12% | 102 |
|
|
2022
Q4 | $1.05M | Buy |
2,879
+29
| +1% | +$10.6K | 0.11% | 112 |
|
|
2022
Q3 | $922K | Sell |
2,850
-55
| -2% | -$17.8K | 0.11% | 101 |
|
|
2022
Q2 | $942K | Hold |
2,905
| – | – | 0.1% | 107 |
|
|
2022
Q1 | $832K | Buy |
2,905
+71
| +3% | +$20.3K | 0.08% | 128 |
|
|
2021
Q4 | $783K | Buy |
2,834
+250
| +10% | +$69.1K | 0.07% | 132 |
|
|
2021
Q3 | $597K | Hold |
2,584
| – | – | 0.06% | 138 |
|
|
2021
Q2 | $593K | Sell |
2,584
-306
| -11% | -$70.2K | 0.06% | 139 |
|
|
2021
Q1 | $540K | Buy |
2,890
+200
| +7% | +$37.4K | 0.06% | 126 |
|
|
2020
Q4 | $454K | Hold |
2,690
| – | – | 0.06% | 119 |
|
|
2020
Q3 | $398K | Hold |
2,690
| – | – | 0.08% | 117 |
|
|
2020
Q2 | $442K | Buy |
2,690
+55
| +2% | +$9.04K | 0.09% | 93 |
|
|
2020
Q1 | $366K | Sell |
2,635
-193
| -7% | -$26.8K | 0.08% | 90 |
|
|
2019
Q4 | $372K | Buy |
2,828
+500
| +21% | +$65.8K | 0.06% | 110 |
|
|
2019
Q3 | $260K | Hold |
2,328
| – | – | 0.05% | 128 |
|
|
2019
Q2 | $258K | Sell |
2,328
-60
| -3% | -$6.65K | 0.05% | 129 |
|
|
2019
Q1 | $310K | Sell |
2,388
-171
| -7% | -$22.2K | 0.06% | 117 |
|
|
2018
Q4 | $296K | Buy |
2,559
+424
| +20% | +$49K | 0.06% | 119 |
|
|
2018
Q3 | $229K | Buy |
+2,135
| New | +$229K | 0.05% | 123 |
|